Ainos Inc (AIMD) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Ainos Inc (AIMD) has a cash flow conversion efficiency ratio of -0.113x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-855.02K) by net assets ($7.56 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Ainos Inc - Cash Flow Conversion Efficiency Trend (1995–2025)
This chart illustrates how Ainos Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read how much debt does Ainos Inc carry for a breakdown of total debt and financial obligations.
Ainos Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Ainos Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
GRAFT POLYMER UK LS -001
F:J4I
|
N/A |
|
CBL International Limited Ordinary Shares
NASDAQ:BANL
|
-0.025x |
|
LEADING HOLDINGS DL-01
F:88Z
|
N/A |
|
Arts-Way Manufacturing Co Inc
NASDAQ:ARTW
|
-0.067x |
|
Massivit 3D Printing Technologies Ltd
TA:MSVT
|
-0.392x |
|
Suryalakshmi Cotton Mills Limited
NSE:SURYALAXMI
|
0.072x |
|
Gaya Abadi Sempurna
JK:SLIS
|
-0.011x |
|
Astute Metals NL
AU:ASE
|
-0.011x |
Annual Cash Flow Conversion Efficiency for Ainos Inc (1995–2025)
The table below shows the annual cash flow conversion efficiency of Ainos Inc from 1995 to 2025. For the full company profile with market capitalisation and key ratios, see Ainos Inc (AIMD) total market value.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $7.56 Million | $-4.61 Million | -0.610x | -63.01% |
| 2024-12-31 | $15.52 Million | $-5.81 Million | -0.374x | -94.93% |
| 2023-12-31 | $24.45 Million | $-4.69 Million | -0.192x | -118.68% |
| 2022-12-31 | $34.63 Million | $-3.04 Million | -0.088x | +28.36% |
| 2021-12-31 | $10.20 Million | $-1.25 Million | -0.123x | -120.57% |
| 2020-12-31 | $-838.28K | $-499.55K | 0.596x | -89.73% |
| 2019-12-31 | $-156.68K | $-909.48K | 5.805x | +519.92% |
| 2018-12-31 | $730.08K | $-1.01 Million | -1.382x | -19.92% |
| 2017-12-31 | $470.80K | $-542.70K | -1.153x | -279.26% |
| 2016-12-31 | $-809.90K | $-520.81K | 0.643x | -17.16% |
| 2015-12-31 | $-472.04K | $-366.41K | 0.776x | -95.70% |
| 2014-12-31 | $-30.74K | $-554.98K | 18.053x | +12898.61% |
| 2013-12-31 | $-4.78 Million | $-664.25K | 0.139x | +17.12% |
| 2012-12-31 | $-4.13 Million | $-489.44K | 0.119x | +57.12% |
| 2011-12-31 | $-4.10 Million | $-309.70K | 0.075x | -56.49% |
| 2010-12-31 | $-3.37 Million | $-584.54K | 0.173x | -8.82% |
| 2009-12-31 | $-4.75 Million | $-903.11K | 0.190x | -40.29% |
| 2008-12-31 | $-2.98 Million | $-948.81K | 0.319x | -42.08% |
| 2007-12-31 | $-2.57 Million | $-1.41 Million | 0.550x | -11.02% |
| 2006-12-31 | $-2.36 Million | $-1.46 Million | 0.618x | +119.77% |
| 2005-12-31 | $-2.33 Million | $-655.39K | 0.281x | +131.01% |
| 2004-12-31 | $-2.69 Million | $-328.05K | 0.122x | +11.52% |
| 2003-12-31 | $-2.52 Million | $-275.36K | 0.109x | -38.24% |
| 2002-12-31 | $-3.07 Million | $-542.13K | 0.177x | +35.76% |
| 2001-12-31 | $-2.84 Million | $-369.86K | 0.130x | -88.45% |
| 2000-12-31 | $-2.41 Million | $-2.72 Million | 1.127x | -99.06% |
| 1999-12-31 | $-47.51K | $-5.67 Million | 119.397x | +11864.00% |
| 1998-12-31 | $2.07 Million | $-2.10 Million | -1.015x | -65.82% |
| 1997-12-31 | $4.43 Million | $-2.71 Million | -0.612x | -112.62% |
| 1996-12-31 | $6.79 Million | $-1.95 Million | -0.288x | -131.00% |
| 1995-12-31 | $-1.40 Million | $-1.30 Million | 0.929x | -- |
About Ainos Inc
Ainos, Inc., a dual-platform AI and biotech company, focusing SmellTech, AI diagnostics, and immune therapeutics. Its AI Nose platform uses a smell language model to digitize scent into Smell IDs and turning invisible chemical signals into machine-readable data. The company is also giving AI for robotics, smart factories, senior care, and women's health. In addition, it develops VELDONA, a low-do… Read more